Search Results
(2S,3R,4S,5S)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-ol 5g | 97%
BLD Pharmatech Ltd.
(2S,3R,4S,5S)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate 5g | 98%
BLD Pharmatech Ltd.
(2S,3R,4S,5S)-5-((R)-1-hydroxy-2-(pivaloyloxy)ethyl)tetrahydrofuran-2,3,4-triyl tris(2,2-dimethylpropanoate)| ChemScene 5g | >98%
ChemScene
(2S,3R,4S,5S)-Tetrahydro-2H-pyran-2,3,4,5-tetraol 25g | 97%
BLD Pharmatech Ltd.
(2S,3R,4S,5S)-Tetrahydro-2H-pyran-2,3,4,5-tetraol 100g | 97%
BLD Pharmatech Ltd.
(2S,3R,4S)-2-Amino-4-hydroxy-3-methylpentanoic acid 5g | 97%
BLD Pharmatech Ltd.
(2S,3R,4S)-2,3,4,5-Tetrahydroxypentanal 25g | 97%
BLD Pharmatech Ltd.
(2S,3R,4S)-2,3,4,5-Tetrahydroxypentanal Please inquire | Purity Not Available
BOC Sciences
(2S,3R,4S)-2,3,4,5-Tetrahydroxypentanal (CAS# 609-06-3) is used in the synthesis of L-Xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
More Information Supplier Page

